background preloader

CaMa sobrevida

Facebook Twitter

Tratamiento del cáncer. Biopsia de ganglio linfático centinela (Revisión: 11 de agosto de 2011) - Hoja informativa que describe el procedimiento de biopsia de ganglio linfático centinela, su uso para determinar la extensión, o estadio, del cáncer en el cuerpo, y los resultados de investigación sobre el uso de este tipo de biopsia en cáncer de seno y melanoma. Cirugía para reducir el riesgo de cáncer de seno (Revisión: 12 de agosto de 2013) - Hoja informativa que describe las clases de cirugía para reducir el riesgo de cáncer de seno y las situaciones en las que se puede pensar en esas operaciones. Cómo encontrar a un doctor o un establecimiento de tratamiento si usted tiene cáncer (Revisión: 05 de junio de 2013) - Hoja informativa que ofrece sugerencias para escoger a un médico y un establecimiento para el tratamiento del cáncer. El tratamiento de niños y adolescentes con cáncer (Revisión: 19 de mayo de 2008) - Hoja informativa sobre los centros oncológicos infantiles y los métodos de tratamiento.

Terapia Adyuvante para el Cáncer de Mama. Los investigadores han estado estudiando el cáncer de seno por muchos años para aprender cómo tratar mejor esta enfermedad. Ellos han prestado particular atención a las formas de prevenir que el cáncer de seno recurra (regrese) después del tratamiento primario. Anteriormente, los científicos pensaban que el cáncer de seno se metastatizaba (diseminaba) primero a los tejidos vecinos y a los ganglios linfáticos de la axila antes de diseminarse a otras partes del cuerpo.

Ahora, los científicos creen que las células cancerosas pueden desprenderse del tumor primario en el seno y que comienzan a metastatizarse aun cuando la enfermedad esté en una etapa inicial. La terapia adyuvante es el tratamiento que se da además de la terapia primaria para matar cualquier célula cancerosa que pueda haberse diseminado, aun cuando la diseminación no puede ser detectada por pruebas radiológicas o de laboratorio. La quimioterapia adyuvante consiste en el uso de fármacos para matar las células cancerosas.

Terapias adyuvantes y neoadyuvantes para el cáncer de seno. What Breast Cancer Survivors Need to Know about Osteoporosis. January 2012 The Impact of Breast Cancer The National Cancer Institute reports that one in eight women in the United States (approximately 13 percent) will develop breast cancer in her lifetime. In fact, next to skin cancer, breast cancer is the most common type of cancer among U.S. women. Although the exact cause is not known, the risk of developing breast cancer increases with age. The risk is particularly high in women age 60 and older. Because of their age, these women are already at increased risk for osteoporosis. Facts About Osteoporosis Osteoporosis is a condition in which the bones become less dense and more likely to fracture.

Risk factors for developing osteoporosis include: Osteoporosis often can be prevented. The Link Between Breast Cancer and Osteoporosis Women who have had breast cancer treatment may be at increased risk for osteoporosis and fracture for several reasons. Studies suggest that chemotherapy also may have a direct negative effect on bone. Resources U.S. Facts & Statistics. Fractures from osteoporosis are more common than heart attack, stroke and breast cancer combined.At least 1 in 3 women and 1 in 5 men will suffer from an osteoporotic fracture during their lifetime.The overall yearly cost to the Canadian healthcare system of treating osteoporosis and the fractures it causes was over $2.3 billion as of 2010.

This cost includes acute care costs, outpatient care, prescription drugs and indirect costs. This cost rises to $3.9 billion if a proportion of Canadians were assumed to be living in long-term care facilities because of osteoporosis. Making a Diagnosis | National Osteoporosis Foundation. A medical evaluation to diagnose osteoporosis and estimate your risk of breaking a bone may involve one or more of the following steps: Other tests that may be used to get information about your bone health, but are not used to diagnose osteoporosis include biochemical marker tests, x-rays, vertebral fracture assessments (VFAs), and bone scans. Medical History Your healthcare provider will ask questions to better understand your risk. Physical Examination Your healthcare provider may measure you to see if you have lost height and examine your spine.

After age 50, you should have your height checked without shoes every year at the same healthcare provider’s office. Bone Density Test A bone density test is the only test that can diagnose osteoporosis before a broken bone occurs. FRAX® - The WHO Fracture Risk Assessment Tool The FRAX® tool uses information about your bone density and other risk factors for breaking a bone to estimate your 10-year fracture risk. Laboratory Tests. Diet and Lifestyle and Survival from Breast Cancer.

While diet and lifestyle have been associated with the risk of getting breast cancer, little is known about the effect of diet and lifestyle on breast cancer survival. Understanding the consequences of diet and lifestyle on breast cancer survival is important to survivors of breast cancer who want to make choices to improve the length and quality of their lives. Far too little is known about the effects of diet and lifestyle after diagnosis on breast cancer survival.

Nonetheless, the results of studies examining these effects are promising although still preliminary. What is the survival rate for women with breast cancer? The current five-year survival rate for women with breast cancer is 86%. (The survival rate is the percentage of women who are still living a period of time after they are diagnosed with breast cancer.) The current ten-year survival rate is 76%. How is breast cancer survival described? Breast cancer survival is described in several ways. What studies need to be done? Survival rates for breast cancer. Some people with cancer may want to know the survival rates for their type of cancer. Others may not find the numbers helpful, or may even not want to know them. Whether or not you want to read about survival rates is up to you. If you decide that you do not want to read about them, skip to the next section. The 5-year survival rate refers to the percentage of patients who live at least 5 years after their cancer is found.

Of course, many people live much longer than 5 years. A relative survival rate compares the survival of people with the cancer to that of people without the cancer. These numbers are based on women treated a number of years ago. While these numbers provide an overall picture, keep in mind that every woman is different and the statistics can't predict exactly what will happen to you. Breast cancer survival statistics. As with the majority of cancers, relative survival for breast cancer is improving. This can generally be attributed to faster diagnosis due to improvements in treatment, raised awareness and the NHS Screening Program.9 However, there is still scope for improvement and increasing cancer survival remains a major priority of Improving Outcomes: A Strategy for Cancer.10 An outcome of this Strategy is the National Awareness and Early Diagnosis Initiative (NAEDI), which is a public sector/third sector partnership between the Department of Health, National Cancer Action Team, and Cancer Research UK.

The role of NAEDI is to promote the earlier diagnosis of cancer, and this will involve researching ways to further improve survival from breast cancer. One-year relative survival has been used as an indicator of early diagnosis, since death before one year is likely to be due to the disease being diagnosed at a late stage. Download this chart Survival is for England only from 1996 onwards. Fundacion Beatriz Beltrones, A.C. para el diagnóstico oportuno del cáncer de la mujer. Cancers currently being updated | Diet and Cancer Report.

Our Global Network is dedicated to funding research and health education programmes into the links between food, nutrition, physical activity, body fatness and cancer risk. April 15, 2014 The CUP database is being kept up to date with all relevant papers from randomised controlled trials and cohort studies published. In July 2013 the database contained 4161 papers on cancers of the breast, colorectum, prostate, pancreas, endometrium, ovary, bladder, kidney, liver, gallbladder, lung, oesophagus and stomach; and polyps and breast cancer survivors. This includes 3683 papers on the different cancers, 146 papers on polyps, and 332 papers on breast cancer survivors. Different cancers The database contains 3683 papers on cancer prevention, including 3566 papers from cohort studies and 117 papers from randomised controlled trials, as shown in the charts below.

Cohort studies Randomised controlled trials Polyps Breast cancer survivors. Prevention and treatment of osteoporosis in w... [Mayo Clin Proc. 2000. Osteopenia and osteoporosis in women with breast... [Semin Oncol. 2003. Cáncer de mama y osteoporosis. El mantener los huesos saludables y fuertes es un tema que causa preocupaciones en todas las mujeres, pero especialmente en las sobrevivientes del cáncer de mama, ya que algunos tratamientos de esta enfermedad pueden ocasionar la pérdida ósea. Si conoce los factores que pueden incrementar el riesgo de desarrollar osteoporosis (una enfermedad que adelgaza y debilita los huesos, lo cual hace que se vuelvan muy frágiles), puede tomar las medidas correspondientes para prevenir o disminuir la pérdida ósea.

Por qué es posible que tenga un riesgo mayor Existen diversas razones por las que las mujeres que se someten a un tratamiento contra el cáncer de mama tienen mayores riesgos de padecer osteoporosis. El tratamiento contra el cáncer de mama puede que incluya el bloqueo o la eliminación de determinadas hormonas que intervienen en el crecimiento de las células cancerosas. El conocimiento es clave Para diagnosticar la osteoporosis se hace una prueba de la densidad ósea.

Breast cancer survival rates by stage. Survival rates are often used by doctors as a standard way of discussing a person's prognosis (outlook). Some patients with breast cancer may want to know the survival statistics for people in similar situations, while others may not find the numbers helpful, or may even not want to know them. If you decide that you do not want to read them, skip to the next section. The 5-year observed survival rate refers to the percentage of patients who live at least 5 years after being diagnosed with cancer. Many of these patients live much longer than 5 years after diagnosis. A relative survival rate (like the numbers below) compares the observed survival with what would be expected for people without the cancer. This helps to correct for the deaths caused by something besides cancer and is a more accurate way to describe the effect of cancer on survival. In order to get 5-year survival rates, doctors have to look at people who were treated at least 5 years ago.